In-Vitro Fertilization (IVF) Devices Market Is Predicted To ...| MENAFN.COM

Friday, 31 March 2023 01:38 GMT

In-Vitro Fertilization (IVF) Devices Market Is Predicted To Surge Ahead At An Impressive CAGR Of 19% By The End Of 2033

(MENAFN- GlobeNewsWire - Nasdaq)

Rockville, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global IVF devices market is valued at US$ 3.12 billion in 2023 and is predicted to reach US$ 17.77 billion by 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider.

Rapidly increasing infertility rates among men and women are boosting sales growth. IVF is also becoming more popular among fertile couples who have hereditary illnesses and don't want to pass them on to their offspring. Advancements in technologies and rising medical tourism across several countries are boosting the demand for in-vitro fertilization (ivf) devices .

A type of assisted reproduction technology known as in-vitro fertilization (IVF) involves the artificial fertilization of the ovum in a lab environment before the ovum is transferred into the uterus. One of the often utilized methods is IVF for helping infertile couples, single parents, and individuals from the LGBT community to have children.

Download Sample Copy of This Report:

Key Takeaways from Market Study

  • The global IVF devices market is expected to surge ahead at a CAGR of 19% from 2023 to 2033.
  • Growing infertility rates in Japan are boosting the demand for IVF devices in the nation.
  • The United States is currently dominating the North American IVF devices market.
  • Germany is a leading market in the European region due to the presence of well-established IVF facilities.

“Rising trend of late marriages and planning for babies at an older age is boosting the demand for IVF devices,” says a Fact.MR analyst.

Recent Market Developments

  • The University of Adelaide and the medical technology business Fertilis introduced an innovative new micro-device in May 2022 to speed up the only reproductive treatment option for males with low semen parameters.
  • Cooper Company purchased Generate Life Sciences in 2021. This company was one of the top suppliers of donor eggs and sperm for assisted reproduction treatments, reproductive cryopreservation services, and neonatal stem cell storage.
  • One of the most well-established IVF treatment providers in the world, Boston IVF, partnered with the Delaware Institute for Reproductive Medicine in January 2022. Through cutting-edge procedures such as in-vitro fertilization (IVF), preimplantation genetic screening, male infertility, and others, the special alliance strives to provide top-notch reproductive treatments and care locally.

Get Customization on this Report for Specific Research Solutions:

Competitive Landscape

Key players in the IVF devices market are producing technologically advanced IVF devices to maintain their market position and increase revenue shares. Major IVF device companies are also focusing on regional expansion by improving local supply chain management systems, changing pricing trends from region to region, and partnerships & collaborations with local IVF device providers.

  • Cook Medical introduced the MINC+ benchtop incubator, a new generation product, in May 2022 in North America. It consists of the DishTrace platform, created to combine capabilities between a PC software application and an incubator touchscreen for several dish-data management solutions.

Key Player's Profiled

  • Cook Group
  • Coopersurgical Fertility Company
  • FUJIFILM Irvine Scientific
  • Thermo Fisher Scientific
  • Fertilis
  • EMD Serono Inc.
  • Vitrolife AB

Trivector Biomed LLP unveiled the ZyMt sperm separation device in October 2020. It is a cutting-edge 'Lab-On-Chip' IVF system. For effective outcomes, separation devices are state-of-the-art labs-on-a-chip that effectively separates the healthiest, fast-developing sperm using microfluidics and micro-filtration technology.

Get Full Access of Complete Report:

Key Segments of IVF Devices Industry Research

  • By Product :
    • Instruments
    • Accessories & Disposables
    • Reagents & Media
  • By Technology :
    • Fresh Embryo IVF
    • Frozen Embryo IVF
    • Donor Egg IVF
  • By End User :
    • Hospitals
    • Fertility Clinics
    • Surgical Centers
    • Clinical Research Institutes
  • By Region :
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global IVF devices market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

The study divulges essential insights on the market on the basis of product (instruments, accessories & disposables, reagents & media), technology (fresh embryo IVF, frozen embryo IVF, donor egg IVF), and end user (hospitals, fertility clinics, surgical centers, clinical research institutes), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Check out more related studies published by Fact.MR Research:

assisted reproductive technology market - The global assisted reproductive technology (ART) market is expected to be worth US$ 24.5 billion in fiscal year 2022. From 2022 to 2032, the market is expected to grow at a 6.2% CAGR, reaching a value of US$ 44.71 billion by the end of 2032.

preimplantation genetic testing market - The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2032.

pregnancy point of care testing market - Growing prevalence of gynecological issues and fertility disorders, coupled with high preference for fast and self-contained tests is primarily boosting sales of pregnancy point of care testing products.

animal pregnancy test kits market - Growing concern of the livestock producers regarding the reproductive efficiency of animals has stimulated the demand and supply of animal pregnancy test kits.

active implantable device market - Stringent regulations related to active implantable devices in certain regions and high cost of implants along with an unfavorable reimbursement scenario in some regions are some of the factors which might hinder the growth of the active implantable device market.

About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Connect to Author: Mr. Shambhu Nath Jha
Email :
Sales Team :
Follow Us: linkedin | twitter | youtube

Tags ivf devices market ivf devices market outlook ivf devices market analysis ivf devices market sale ivf devices demand Related Links

  • plasma fractionation market demand
  • multimodal imaging market demand
  • manual resuscitators market demand
  • air ambulance services market demand
  • anti-infective agents market demand
  • voice prosthesis devices market demand
  • veterinary surgical instruments market demand
  • urinary catheters market demand


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.